PolyAI vs UiPath

PolyAI Launches Audio-Native Voice AI Model Dialog-RSN-1

PolyAI introduced Dialog-RSN-1, an audio-native dialog model for enterprise voice agents. The model fuses speech recognition, turn-taking, function calling, and response generation into a single large language model that reasons directly over raw call audio. Output is handled by a separate text-to-speech system to maintain control over the caller-experienced voice. PolyAI claims sub-300ms latency in production, positioning the model against cascaded architectures and speech-to-speech models like GPT Realtime and Gemini Live. The initial release supports English only, with broader language support planned. The announcement follows an $86 million Series D closed in December 2025.

• PolyAI introduced Dialog-RSN-1 on July 30, 2026.
• Dialog-RSN-1 reasons over raw audio for input while using a separate TTS for output.
• PolyAI reports sub-300ms response latency in live production calls.

UiPath Recognized as a Leader in the Gartner® Magic Quadrant™ for Business Orchestration and Automation Technology

UiPath has been named a Leader in the Gartner Magic Quadrant for Business Orchestration and Automation Technology, and also positioned as a Leader in the Gartner Magic Quadrant for Intelligent Document Processing for the second straight year.

8-K Financial Filing Analysis for UiPath (2026-09-03)

UiPath, Inc. announced comprehensive executive leadership and governance updates effective September 3, 2026. Hitesh Ramani, previously Deputy CFO and Chief Accounting Officer, has been promoted to Chief Financial Officer, allowing Ashim Gupta to focus exclusively on his role as Chief Operating Officer. Concurrently, Brad Brubaker transitioned to Chief Legal & Administrative Officer, and the Board expanded to eight members with the appointment of Kaiser Permanente EVP Yazdi Bagli as an independent director. In addition, CEO Daniel Dines adopted a Rule 10b5-1 trading plan to sell up to 5,000,000 Class A common shares through February 1, 2027.

• Hitesh Ramani was promoted to CFO with a base salary of $470,000, a 50% target bonus, and 130,368 RSUs, succeeding Ashim Gupta, who remains Chief Operating Officer.
• The Board of Directors expanded from seven to eight seats, appointing Kaiser Permanente EVP Yazdi Bagli as an independent director effective September 3, 2026.
• CEO Daniel Dines adopted a Rule 10b5-1 trading arrangement to sell up to 5,000,000 Class A common shares through February 1, 2027.

10-Q Financial Filing Analysis for UiPath (2026-09-08)

UiPath, Inc. reported its financial results for the second quarter of fiscal 2027 ended July 31, 2026, delivering total revenue of $410.3 million, a 13% increase year-over-year, alongside an operating income of $31.6 million compared to an operating loss of $20.2 million in the prior-year period. Annualized renewal run-rate (ARR) expanded 12% year-over-year to $1.94 billion, supported by a dollar-based net retention rate of 109% and enterprise adoption of its agentic automation capabilities. Net income reached $36.1 million ($0.07 per diluted share), while six-month operating cash flow remained robust at $162.6 million. During the first half of fiscal 2027, UiPath deployed capital toward strategic acquisitions and shareholder returns, completing the acquisition of WorkFusion, Inc. for $189.5 million in total consideration and repurchasing $268.5 million of Class A common stock. Liquidity remained strong with $1.41 billion in cash, cash equivalents, and marketable securities as of July 31, 2026.

• Q2 FY2027 revenue reached $410.3 million (up 13% YoY) with ARR growing 12% YoY to $1.938 billion and dollar-based net retention rate at 109%.
• Operating income shifted to positive $31.6 million (operating margin 8%) from an operating loss of $20.2 million in Q2 FY2026, driving quarterly net income of $36.1 million.
• Cash, cash equivalents, and marketable securities totaled $1.405 billion as of July 31, 2026, after deploying $149.4 million net cash for the WorkFusion acquisition and $268.5 million for Class A share repurchases in H1 FY2027.